Sequent Scientific has informed that the Hon’ble National Company Law Tribunal, Mumbai Bench vide its Order dated March 9, 2018 issued on March 22, 2018 has approved the Composite Scheme involving demerger of Commodity API business of Strides and Human API Business of SeQuent into Solara under the provisions of Sections 230 - 232 and other applicable provisions of the Companies Act, 2013. The Appointed Date for the Demerger is October 1, 2017. The Company shall soon notify the Effective Date of De-merger and the Record Date for determining the entitlement of shareholders to whom Solara will allot shares consequent to the demerger.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: